Jul 1, 2019
Legal Drugs Podcast host, Angela Stoyanovitch, walks you through her early career history that led her an interest in how drugs are brought to market. The journey or idea of a drug that is discovered in academia does not always have a linear pathway to industry. A drug in development may not end up where you may have intended it with many turns and re-routes along the way.
How could a drug with indications around cancer turn into a sex behavior drug, for example? How could a cardiovascular drug turn into a sex behavior indication?
Young Investigator, Angela, developed a curiosity for this unknown world into drug development and became addicted to the industry with her early work in sex behavior research.